Sometimes the universe aligns, and this was clearly so for 101CBD.org at CannMed 2019 in Pasadena last week. The medical cannabis convention focused on Dr. Raphael Mechoulam, the “Godfather” of Cannabis who has spent 56 years researching cannabis plants and actually identified the CBD and THC molecules, their raw precursors CBDA and THCA, and the Endocannabinoid System (ECS) of body receptors responsive to the range of cannabinoids. CBDA was the message at the convention with multiple health benefits and the need to provide researchers a stable CBDA molecule for further medical research in human health.
The focus on CBDA and health research totally aligns with our mission here at 101 CBD. Our hemp-based whole plant extract and products maintain a stable CBDA, currently testing at 75%+ of our cannabinoids. Putting that high percentage CBDA with the whole plant range of cannabinoids, terpenes, lipids, and flavonoids and a low .02 % THC level provides an organic powerhouse of ingredients to interact with the ECS and beyond.
We are currently seeking university research partners to document the range of benefits of this unique CBDA product, to explore the ideal administration methods and usage amounts, and the pharmacokinetics and pharmacodynamics. We are also seeking laboratories to analyze CBDA blood serum levels.
We can not express the excitement of this CannMed Conference, the constant stream of professionals from a wide variety of areas exchanging information with our staff. We are excited to follow up with anyone we met or anyone who had unanswered questions. Collaboration with all facets of the cannabis world are so important as the field moves forward. The spirit of the 2019 CannMed Conference for us at 101CBD.org was best expressed by our “The Godfather of Cannabis” themed booth in honor of Dr. Mechoulam and the famous movie line: “Leave the CBD, Take the CBDA!”
